LABELQ is designed to deliver fully automatic label inspection with real-time feedback, ensuring every label is verified to the highest standard.

USA – Verista, a leading provider of automation, compliance, and quality solutions for the pharmaceutical industry, unveils the LABELQ Label & Print Reconciliation System, a platform engineered to transform label management for medical devices, pharmaceutical, and contract manufacturers.
The LABELQ is designed to streamline operations by integrating print, inspection, and accountability into a single, unified platform.
Designed to streamline operations, LABELQ integrates print, inspection, and accountability into a single, unified platform, ensuring maximum efficiency and reducing operational complexity for small- to medium-sized batch production environments.
Furthermore, LABELQ is designed to deliver fully automatic label inspection with real-time feedback, ensuring every label is verified to the highest standard.
This label inspection capability safeguards both brand reputation and end-customer trust by minimising the risk of product recalls, label mix-ups, and poor label quality.
Through automated record-keeping and audit logging, LABELQ ensures compliance with 21 CFR Part 11, providing full traceability while streamlining operations by eliminating manual inspections and reducing production expenses.
The LABELQ platform delivers adaptable, industrial-grade solutions, making it well-suited for manufacturers with variable production demands.
The system enables swift, two-step changeovers, reducing downtime and boosting productivity. This feature allows for seamless switching between different products or batches, significantly reducing the time and resources required for changeovers.
The intuitive train-and-deploy setup is designed to streamline the onboarding of new products. It simplifies the setup process, cutting down time-to-market and making it easier for operators to learn and deploy the system for new products.
LABELQ provides a versatile range of operational modes designed to optimise label management processes.
It enables printing, inspection, and accurate counting of good labels until the required lot size is achieved.
When using Bartender label templates, LABELQ can automatically generate vision files, thus ensuring consistency across lots without the need for multiple template variations.
Additionally, LABELQ incorporates reject marking and automatic print stoppage for defective labels, ensuring full accountability for all printed output.
To meet regulatory standards, LABELQ also delivers comprehensive 21 CFR Part 11-compliant reporting for entire lots, with full traceability and detailed logging of both user and system events.
The highly adaptable LABELQ platform supports a range of configurations, including inspection-only, combined print-and-inspect functions, label ablation, and more, to meet diverse operational needs, instilling confidence in its versatility.
The LABELQ platform accommodates lot sizes ranging from 50 to 50,000, making it well-suited to meet the diverse production requirements of both medical device and pharmaceutical manufacturers.
Verista’s LABELQ solution redefines label management by providing a comprehensive platform that streamlines operations, guarantees regulatory compliance, and drives tangible performance improvements for regulated sectors.
Subscribe to our email newsletters that provide busy executives like you with the latest news insights and trends from Africa and the World. SUBSCRIBE HERE
Be the first to leave a comment